Ester Amado

422 total citations
23 papers, 295 citations indexed

About

Ester Amado is a scholar working on Geriatrics and Gerontology, Epidemiology and Family Practice. According to data from OpenAlex, Ester Amado has authored 23 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Geriatrics and Gerontology, 6 papers in Epidemiology and 5 papers in Family Practice. Recurrent topics in Ester Amado's work include Pharmaceutical Practices and Patient Outcomes (11 papers), Chronic Disease Management Strategies (6 papers) and Medication Adherence and Compliance (5 papers). Ester Amado is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (11 papers), Chronic Disease Management Strategies (6 papers) and Medication Adherence and Compliance (5 papers). Ester Amado collaborates with scholars based in Spain. Ester Amado's co-authors include Enriqueta Pujol‐Ribera, Josep M. Borràs, Pérez Rodríguez, José Luis del Val García, Concepción Violán, Valeria Pacheco‐Huergo, Carme Viladrich, Montserrat Núñez, Sergio Fernández‐Bertolín and Carmen Cabezas and has published in prestigious journals such as Diabetes Care, Medical Care and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Ester Amado

23 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Amado Spain 11 80 75 61 57 56 23 295
Ryan P. Hickson United States 11 67 0.8× 59 0.8× 33 0.5× 83 1.5× 87 1.6× 18 330
E. Paul Larrat United States 11 132 1.6× 63 0.8× 51 0.8× 40 0.7× 72 1.3× 19 360
Emily P. Peron United States 10 139 1.7× 116 1.5× 99 1.6× 44 0.8× 49 0.9× 25 446
A. Janoly-Duménil France 13 125 1.6× 51 0.7× 64 1.0× 61 1.1× 87 1.6× 48 392
Nicole T. Ansani United States 11 71 0.9× 89 1.2× 115 1.9× 52 0.9× 111 2.0× 18 495
R.P. Sequeira Bahrain 13 143 1.8× 47 0.6× 46 0.8× 58 1.0× 29 0.5× 26 347
Maria Dolores Nieto‐Martín Spain 11 204 2.5× 49 0.7× 67 1.1× 79 1.4× 73 1.3× 31 389
Lisa C. Hutchison United States 10 182 2.3× 57 0.8× 38 0.6× 45 0.8× 58 1.0× 26 391
Ashenafi Kibret Sendekie Ethiopia 10 80 1.0× 43 0.6× 49 0.8× 25 0.4× 72 1.3× 61 324
Elinor C. Chumney United States 12 165 2.1× 51 0.7× 52 0.9× 69 1.2× 64 1.1× 17 412

Countries citing papers authored by Ester Amado

Since Specialization
Citations

This map shows the geographic impact of Ester Amado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Amado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Amado more than expected).

Fields of papers citing papers by Ester Amado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Amado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Amado. The network helps show where Ester Amado may publish in the future.

Co-authorship network of co-authors of Ester Amado

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Amado. A scholar is included among the top collaborators of Ester Amado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Amado. Ester Amado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simó, Rafael, Josep Franch‐Nadal, Bogdan Vlacho, et al.. (2023). Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes. Diabetes Care. 46(9). 1633–1639. 18 indexed citations
2.
García, José Luis del Val, et al.. (2023). Fracture risk after deprescription of bisphosphonates: Application of real-world data in primary care. Atención Primaria. 55(7). 102651–102651. 1 indexed citations
3.
Guisado‐Clavero, Marina, Sergio Fernández‐Bertolín, Quintí Foguet‐Boreu, et al.. (2020). Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study. BMC Geriatrics. 20(1). 26 indexed citations
4.
López‐Jiménez, Tomás, Albert Roso‐Llorach, Ester Amado, et al.. (2020). Medication‐related problems in older people in Catalonia: A real‐world data study. Pharmacoepidemiology and Drug Safety. 30(2). 220–228. 15 indexed citations
6.
Grau, María, José Luis del Val García, Ester Amado, et al.. (2017). Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors: A pre-post controlled study. Atención Primaria. 49(7). 389–398. 10 indexed citations
7.
Amado, Ester, et al.. (2015). Información de medicamentos a pacientes: necesaria pero insuficiente. FMC - Formación Médica Continuada en Atención Primaria. 22(2). 90–97. 2 indexed citations
8.
Amado, Ester, et al.. (2015). Characterizing chronic disease and polymedication prescription patterns from electronic health records. QRU Quaderns de Recerca en Urbanisme. 1–9. 10 indexed citations
9.
Amado, Ester, et al.. (2014). Seguridad del paciente en atención primaria: proyecto PREFASEG (PREscripción FArmacológica SEGura). Medicina Clínica. 143. 32–35. 7 indexed citations
10.
Verdú-Rotellar, José María, José Luis del Val García, María Grau, et al.. (2013). Impact of the implementation of electronic guidelines forcardiovascular prevention in primary care: study protocol. Journal of Innovation in Health Informatics. 20(2). 129–139. 3 indexed citations
11.
Martin, M., et al.. (2013). Factores de riesgo cardiovascular en el tratamiento crónico con antipsicóticos en atención primaria. Revista de Neurología. 57(11). 495–495. 6 indexed citations
12.
Amado, Ester, et al.. (2011). Prescripció farmacèutica segura (PREFASEG). 94(1). 2–3. 3 indexed citations
13.
Amado, Ester, et al.. (2011). Knowledge and adherence to antihypertensive therapy in primary care: results of a randomized trial. Gaceta Sanitaria. 25(1). 62–67. 53 indexed citations
14.
Pacheco‐Huergo, Valeria, Carme Viladrich, Enriqueta Pujol‐Ribera, et al.. (2011). Percepción en enfermedades crónicas: validación lingüística del Illness Perception Questionnaire Revised y del Brief Illness Perception Questionnaire para la población española. Atención Primaria. 44(5). 280–287. 55 indexed citations
15.
Bolíbar, Ignasi, Vicente Plaza, Ester Amado, et al.. (2009). Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease. BMC Public Health. 9(1). 68–68. 10 indexed citations
16.
Amado, Ester, et al.. (2008). Adecuación de la prescripción de antiinflamatorios no esteroideos y gastroprotección en atención primaria. Atención Primaria. 40(11). 559–564. 4 indexed citations
17.
18.
Amado, Ester, et al.. (2000). Relación entre calidad y coste de la prescripción farmacológica en atención primaria. Atención Primaria. 25(7). 464–468. 10 indexed citations
19.
Amado, Ester, et al.. (1997). [Is the profile of antihypertensive drug utilization justified?].. PubMed. 20(10). 530–4. 4 indexed citations
20.
Amado, Ester, et al.. (1997). [Analysis of prescriptions in primary care: evaluation of a system of indicators].. PubMed. 20(7). 381–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026